Tuesday, April 07, 2026 1:28:00 PM
BDRX...$3.31...🥳...Zero Shares to Borrow with 60% Fee and NO Rebate...Tiny Float Post Split...Same set up as SKYQ which I called at $2.50 and sold at $7.60s...
Fee Rebate Available Updated
60.59% 0.00% 0 2026-04-06 17:36:35
60.59% 0.00% 0 2026-04-06 17:21:00
60.59% 0.00% 0 2026-04-06 17:05:29
60.59% 0.00% 0 2026-04-06 16:49:57
60.59% 0.00% 0 2026-04-06 16:34:26
60.59% 0.00% 0 2026-04-06 16:34:26
Fee Rebate Available Updated
60.59% 0.00% 0 2026-04-06 17:36:35
60.59% 0.00% 0 2026-04-06 17:21:00
60.59% 0.00% 0 2026-04-06 17:05:29
60.59% 0.00% 0 2026-04-06 16:49:57
60.59% 0.00% 0 2026-04-06 16:34:26
60.59% 0.00% 0 2026-04-06 16:34:26
Recent BDRX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2026 08:00:10 PM
- Biodexa issues letter to Shareholders • GlobeNewswire Inc. • 05/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:29 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:29 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:27 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:27 PM
- Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:17 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 09:00:06 PM
- Preliminary Results for the Year Ended 31 December 2025 • GlobeNewswire Inc. • 03/27/2026 09:00:00 PM
- Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group • GlobeNewswire Inc. • 03/23/2026 12:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:19:51 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/18/2026 09:11:41 PM
- ADR Ratio Change • GlobeNewswire Inc. • 03/18/2026 09:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:12 PM
